EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, is now recruiting
Cure Parkinson’s is excited to announce that the first multi-arm multi-stage clinical trial platform for Parkinson’s in the UK – EJS ACT-PD – is underway, with recruitment now open to people with Parkinson’s. The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD)...
Learn more
Webinar: Deep Brain Stimulation (DBS) for Parkinson’s: The next steps
Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair, this edition of our quarterly webinar series focused on DBS. Deep Brain Stimulation (DBS) is a surgical treatment for Parkinson’s that involves implanting…
Cure Parkinson’s Fundraising Heroes: July 2025
Our amazing Fundraising Heroes took advantage of the summer sunshine to take on some incredible challenges. Walking the Pembrokeshire Coast Path Steve (who lives with Parkinson’s) and his wife Elaine walked part of the Pembrokeshire Coast Path for us, and more than doubled their fundraising…
Rallying to the Challenge 2025: recorded to watch again
Rallying to the Challenge is a meeting held in partnership with Cure Parkinson’s and Van Andel Institute, designed for people with Parkinson’s, advocates, and care partners to explore how the Parkinson’s community can impact and accelerate research. Each year, the meeting focuses on an aspect…
2026 London to Brighton Bike Ride
Sign up for the oldest and most iconic charity bike ride in Europe and raise funds for Cure Parkinson’s! Starting at Clapham Common, the 54 mile cycle will take you through the capital to the beautiful countryside of the South Downs all the way to...
Walk To Cure Parkinson’s: The London Walk
Join us in our 20th year as we Walk To Cure Parkinson’s! After being diagnosed with Parkinson’s at 26, Tom Isaacs took on the epic challenge of walking the 4,500 miles coastline of Great Britain. After completing his walk, Tom and friends started the charity...

